Brief: Interpace Diagnostics Sees 2019 Revenue Up 25%

Interpace Biosciences

13/05/2019 22:50

May 13 (Reuters) - Interpace Diagnostics Group Inc  IDXG.O :
    * INTERPACE DIAGNOSTICS REPORTS FIRST QUARTER 2019 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * SEES FY 2019 REVENUE UP 25 PERCENT
    * SEES FY 2019 REVENUE $27 MILLION TO $28 MILLION
    * Q1 REVENUE $6.01 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$6.3
MILLION
    * FY2019 REVENUE VIEW $27.9 MILLION -- REFINITIV IBES DATA
    * QTRLY NET LOSS PER DILUTED SHARE OF COMMON STOCK $0.10
    * Q1 EARNINGS PER SHARE VIEW $-0.06 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXHcsZM 
Further company coverage:  IDXG.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))